spacer
home > pmps > autumn 2017 > convenience, compliance and cartons
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Convenience, Compliance and Cartons

PMPS: Patient adherence is a current hot topic. Why is it of such interest to the industry?

Dr Daniel Keesman: Pharmaceutical companies lose hundreds of billions of dollars every year due to the fact that patients do not stick to their medication plan or do not take the prescribed medicine. Not only do they want to prove that their drugs are effective, pharma companies have an interest in improving adherence and compliance.

In your experience, what have been the biggest obstacles to adherence in pharma packaging over the past 10 years?

Primary packaging has improved in recent years, for instance, by inventing auto injection devices and pens to prevent the patient from seeing the scary needle. Secondary packaging is, unfortunately, very often thrown away, as it only serves as a transportation and value protection. Further, the leaflets are not put into the folding carton again after first use as nobody is able to fold them back to the same size it was when delivered.

Technical devices supporting adherence that could be attached to the packaging such as displays or near-field communication chips that can be connected to smartphones only make sense when the drug itself is worth having a packaging that costs 5-20 times more than without such a device.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Daniel Keesman, son of a German mother and a Dutch father, was born in New York, US, and is therefore still an American. For nearly 10 years, he has been part of the executive board of the quality-oriented pharmaceutical packaging manufacturer. He entered August Faller Group as Managing Partner in 2009 and is responsible for the development of national and international markets.
spacer
Dr Daniel Keesman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Philadelphia, USA October 15, 2018. Leading international pharmaceutical outsourcing services provider PCI Clinical Services (PCI) has announced the completion of a dedicated Returns Management facility at its Clinical Services Center of Excellence at Bridgend, UK. PCI provides a full service Returns Management service for clients, providing visibility and accountability in returning investigational drug product from investigational sites at the conclusion of a clinical study. Returning and reconciling Investigational Medicinal Product (IMP) on completion of a study is a critical part of a Clinical trial and can require complex reverse logistics. Trial outcomes can be impacted if Returns are not processed efficiently and precisely.
More info >>

White Papers

Advanced BioDesign Outlines Solutions

Advanced BioDesign

Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >>

 
Industry Events

10th Annual Summit for Clinical Ops Executives

18-21 February 2019, Hyatt Regency Orlando, Florida

Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including...
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement